THE BOARD’S PRESENTATION
Johan Vandenbroucke
Chairman of the board
Johan had an active carrier of 40 years in the university hospital of Ghent-Belgium where he was the responsible pharmacist for the production unit. He was a member of the Belgian Oncology Pharmacy Practitioners, the European Society Oncology Pharmacists and the European Association Hospital Pharmacies. He has been an active member of the International Society Oncology Pharmacy Practitioners for already more than 20 years. In ISOP, he took the position of treasurer, president-elect and president and was one of the co-chairs of the standards committee, who delivered the international standard on safe handling of hazardous drugs in 2007. He lectured on many occasions on the topic of safe handling, CSTD and organisation of the oncology flow in the hospital/day clinic across the world and organized theoretical and practical training courses for international colleagues.
Dr. Hélène Levert
Board Member
Hélène Levert obtained a Ph.D. in pharmacology, before becoming hospital practitioner and head of the medical devices sector at the CHU Saint-Louis (Assistance Publique-Hôpitaux de Paris) in 2006. Her real field of predilection are MD for drugs infusion.
Ms. Alison Simons
Board Member
Alison was a cancer nurse for 18 years. She joined Birmingham City University in 2009 as a Senior Lecturer and Pathway Leader for cancer and chemotherapy. She has always had a passion for nurse education and in particular SACT safety for nurses administering SACT. This has led her to campaign in raising awareness for nurses and undertaking research in this area of study.
Mr. Seth Einserberg
Board Member
Practicing in the field of oncology since 1983, my experience includes more than 30 years in Blood and Marrow Transplant (BMT) at the Fred Hutchinson Cancer Research Center / Seattle Cancer Care Alliance.
My publishing experience includes numerous peer-reviewed articles on chemotherapy and biotherapy, four book chapters including a chapter for the Joint Commission Resources on Closed System Transfer Devices (CSTDs), and having served as editor for a book on BMT. I have presented nationally and internationally at nursing and pharmacy conferences on a variety of topics and have been the principal investigator in two published nursing research studies, with the results of a wipe test project slated for early 2021 publication.
Ms. Samantha Toland
Board Member
Sam has been a cancer / haemato-oncology nurse for 20 years. Having worked initially in Haemato-oncology and stem cell transplant, she then went on to become a Chemotherapy nurse trainer, responsible for the chemotherapy training and education of all nursing staff in a large teaching hospital trust. During this time, she also commenced her post at Birmingham City University as a senior lecturer in Haemato-oncology and chemotherapy. She has also had roles as a Leukaemia Nurse Specialist, an Acute Oncology Nurse Practitioner, and is currently a Lead Chemotherapy Nurse of a large acute hospital trust. She is also the Chair of the West Midlands Cancer Alliance SACT EAG, and a member of the National Clinical Reference Group for Chemotherapy.
Dr. Luis Mazon
Board Member
Luis Mazón Cuadrado, MD, is Chief of the Division of Occupational Medicine of the University Hospital Fuenlabrada and Head of The Spanish Association for Standardisation (UNE) for Closed System Transfer Devices (CSTD). He is a specialist in occupational risk prevention, safety at work, industrial hygiene, ergonomics and applied social psychology with over 20 years of experience as coordinator of preventive medicine.
He has been Head of the Teaching Unit of Laboral Medicine of Madrid and National Secretary of the International Commission of Occupational Health, helping as an advisor for The World Health Organization (WHO) and The International Labour Organization (ILO). He has coordinated the Latin American Biosafety Network and counsel the Health Minister of Colombia to develop their National Biosafety Law. Moreover, he is a member of the Sharps Safety European Group, The International Commision Occupational Health (ICOH) and The Madrid Regional Health System (SERMAS).
Mr. Fred Massoomi
Board Member
RPh, Pharm.D., FASHP – Visante, Inc; Senior Director for Hospitals and Health-system Services
Fred Massoomi is currently a Senior Director with Visante, where he provides assessments and consultation to healthcare practices with the ultimate goal of providing medications to patients in the safest manner.
Prior to his work with Visante, Fred has worked with multiple Pharmacy Departments, and led great teams with embracing and implementing programs based on best practices, safety guidelines, safe hazardous drug handling and proper disposal of pharmaceutical drug waste. In an effort to educate healthcare providers on the risks and best practices to protect themselves and the environment, he has had the opportunity to present at numerous national and international meetings.
Mr. Matthew Fowler
Board Member
Matt is a Oncology/Haematology Consultant Nurse at Birmingham Heartlands Hospital. Matt’s interests lie in advanced practice in cancer nursing, vascular access care and the management of low risk febrile neutropenia. Matt holds a MSc in Nursing, a Post Graduate Certificate in Advanced Clinical Practice from Warwick University. Matt regularly teaches undergraduate and postgraduate nurses, including the higher diploma in oncology and palliative care nursing at Bethlehem University.
Paul Sessink
Previous chairman
Paul Sessink studied chemistry at the University of Nijmegen in The Netherlands and has a PhD in Medical Sciences.
He is founder of Exposure Control, a consulting firm that offers methods for monitoring occupational exposure to hazardous drugs in hospitals and in the pharmaceutical industry.
About 300 hospitals have been monitored over the last 20 years. He is co-author of approximately 40 scientific publications on exposure to cytotoxic drugs.